Phio Pharmaceuticals Reaches Key Milestone in Advancing Lead Candidate PH-762
Nitto Denko Avecia begins first commercial-scale cGMP production of PH-762 drug substance Phio Pharmaceuticals Corp. (NASDAQ:PHIO) KING OF PRUSSIA, PA, UNITED STATES, June 25, 2026 /EINPresswire.com/ -- Phio Pharmaceuticals Corp. (NASDAQ: PHIO …